Shanghai, China

Jiangwei Zhang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):

Title: Jiangwei Zhang: Innovator in Cancer Treatment

Introduction

Jiangwei Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment, particularly in the development of drugs targeting specific mutations. With a total of 5 patents, his work is paving the way for innovative therapies.

Latest Patents

Jiangwei Zhang's latest patents include groundbreaking methods for treating tumors with specific genetic mutations. One notable patent is focused on the use of a FAK inhibitor in the preparation of a drug for treating tumors that have an NRAS mutation. This method involves administering an effective dose of a FAK inhibitor to individuals with such tumors. The FAK inhibitors mentioned include B1853520, defactinib, GSK2256098, PF-00562271, VS-4718, or their pharmaceutically acceptable salts. Another significant patent relates to the use of BI853520 in cancer treatment, which details a method for treating tumors with a KRAS mutation using a specific compound or its pharmaceutically acceptable salt.

Career Highlights

Jiangwei Zhang is currently associated with Inxmed (Nanjing) Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative solutions for complex medical challenges.

Collaborations

Jiangwei has collaborated with notable colleagues, including Zaiqi Wang and Jun Jiang, to further enhance the impact of his research in the field of oncology.

Conclusion

Jiangwei Zhang's contributions to cancer treatment through his innovative patents and collaborative efforts highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in targeted therapies for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…